Security key
88338N206
TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)
CUSIP: 88338N206
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 11,676,558
- Total 13F shares
- 3,031,054
- Share change
- -84,102
- Total reported value
- $12,488,021
- Put/Call ratio
- 67%
- Price per share
- $4.12
- Number of holders
- 40
- Value change
- -$296,992
- Number of buys
- 12
- Number of sells
- 9
Report period
Q2 2023
Institutions
40
Top holders
10
TXMD full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
TherapeuticsMD, Inc. SEC filings
TherapeuticsMD, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 88338N206
Recent filing periods:
Top shareholders of TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Rubric Capital Management LP |
13F
|
Company |
10%
|
1,192,191
|
$4,470,716 | — | 31 Mar 2023 | |
| Clearline Capital LP |
13F
|
Company |
3.6%
|
419,425
|
$1,572,844 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.3%
|
385,248
|
$1,444,680 | — | 31 Mar 2023 | |
| Tejara Capital Ltd |
13F
|
Company |
3%
|
355,679
|
$1,333,796 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
133,728
|
$501,480 | — | 31 Mar 2023 | |
| Sixth Street Partners Management Company, L.P. |
13F
|
Company |
1.1%
|
124,659
|
$467,471 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.99%
|
116,132
|
$435,496 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.7%
|
81,781
|
$306,678 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.45%
|
52,521
|
$196,954 | — | 31 Mar 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.36%
|
42,000
|
$157,500 | — | 31 Mar 2023 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.33%
|
38,042
|
$142,658 | — | 31 Mar 2023 | |
| SANDERS MORRIS HARRIS LLC |
13F
|
Company |
0.29%
|
33,577
|
$125,914 | — | 31 Mar 2023 | |
| GABELLI FUNDS LLC |
13F
|
Company |
0.27%
|
31,000
|
$116,250 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.26%
|
30,130
|
$112,988 | — | 31 Mar 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.19%
|
22,480
|
$84,300 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.13%
|
15,725
|
$58,969 | — | 31 Mar 2023 | |
| J. Goldman & Co LP |
13F
|
Company |
0.12%
|
13,562
|
$50,858 | — | 31 Mar 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.08%
|
8,770
|
$32,888 | — | 31 Mar 2023 | |
| FMR LLC |
13F
|
Company |
0.07%
|
8,289
|
$31,084 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0.05%
|
5,510
|
$20,663 | — | 31 Mar 2023 | |
| Cantonale Vaudoise Banque |
13F
|
Individual |
0.01%
|
1,000
|
$4,000 | — | 31 Mar 2023 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0.01%
|
720
|
$2,679 | — | 31 Mar 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
619
|
$3,000 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
576
|
$2,160 | — | 31 Mar 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
517
|
$1,937 | — | 31 Mar 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
408
|
$1,531 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
310
|
$1,188 | — | 31 Mar 2023 | |
| US BANCORP \DE\ |
13F
|
Company |
0%
|
246
|
$923 | — | 31 Mar 2023 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
140
|
$525 | — | 31 Mar 2023 | |
| HUNTINGTON NATIONAL BANK |
13F
|
Company |
0%
|
120
|
$450 | — | 31 Mar 2023 | |
| WealthPLAN Partners, LLC |
13F
|
Company |
0%
|
95
|
$356 | — | 31 Mar 2023 | |
| Cedar Mountain Advisors, LLC |
13F
|
Company |
0%
|
40
|
$150 | — | 31 Mar 2023 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
16
|
$77 | — | 31 Mar 2023 | |
| Focused Wealth Management, Inc |
13F
|
Company |
0%
|
16
|
$60 | — | 31 Mar 2023 | |
| PRIVATE TRUST CO NA |
13F
|
Company |
0%
|
16
|
$60 | — | 31 Mar 2023 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
11
|
$41 | — | 31 Mar 2023 | |
| HARBOUR INVESTMENTS, INC. |
13F
|
Company |
0%
|
8
|
$30 | — | 31 Mar 2023 | |
| Guardian Wealth Management, Inc. |
13F
|
Company |
0%
|
2
|
$8 | — | 31 Mar 2023 | |
| Aspire Private Capital, LLC |
13F
|
Company |
0%
|
1
|
$4 | — | 31 Mar 2023 | |
| John C.k. Milligan IV |
3/4/5
|
Secretary/CEO of subsidiary |
—
mixed-class rows
|
5,542,076
mixed-class rows
|
$12,698,322 | — | 10 May 2021 | |
| Hugh O'Dowd |
3/4/5
|
Chief Executive Officer |
—
mixed-class rows
|
4,250,000
mixed-class rows
|
$11,415,713 | — | 31 Mar 2022 | |
| Robert G. Finizio |
3/4/5
|
CEO, Director |
—
mixed-class rows
|
2,240,000
mixed-class rows
|
$5,305,888 | — | 01 Jul 2021 | |
| James Darecca |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
558,163
mixed-class rows
|
$1,857,402 | — | 10 Aug 2021 | |
| Edward Borkowski |
3/4/5
|
EVP, Operations |
—
mixed-class rows
|
560,000
mixed-class rows
|
$1,326,472 | — | 01 Jul 2021 | |
| J. Martin Carroll |
3/4/5
|
Director |
—
class O/S missing
|
106,864
|
$239,268 | — | 10 Aug 2021 | |
| Michael C. Donegan |
3/4/5
|
Prin. Fin. and Acctg. Officer |
—
class O/S missing
|
61,853
|
$138,489 | — | 12 Apr 2023 | |
| Brian Bernick |
3/4/5
|
Co-Chief Executive Officer |
—
mixed-class rows
|
14,449
mixed-class rows
|
$47,065 | — | 06 Dec 2022 | |
| Angus C. Russell |
3/4/5
|
Director |
—
class O/S missing
|
5,000
|
$18,191 | — | 29 Sep 2022 | |
| Jules A. Musing |
3/4/5
|
Director |
—
class O/S missing
|
5,000
|
$18,191 | — | 29 Sep 2022 | |
| Karen Ling |
3/4/5
|
Director |
—
class O/S missing
|
5,000
|
$18,191 | — | 29 Sep 2022 |
Institutional Holders of TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD) as of Q2 2023
As of 30 Jun 2023,
TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,031,054 shares.
The largest 10 holders included
Rubric Capital Management LP, Clearline Capital LP, VANGUARD GROUP INC, Tejara Capital Ltd, BlackRock Inc., MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and GABELLI FUNDS LLC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
38
Q2 2023 holders
40
Holder diff
2
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.